Free Trial

Maximus, Inc. (NYSE:MMS) Shares Sold by Victory Capital Management Inc.

Maximus logo with Business Services background

Victory Capital Management Inc. lowered its position in Maximus, Inc. (NYSE:MMS - Free Report) by 70.3% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 922,612 shares of the health services provider's stock after selling 2,187,120 shares during the quarter. Victory Capital Management Inc. owned approximately 1.53% of Maximus worth $85,951,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Entropy Technologies LP acquired a new position in Maximus during the 3rd quarter worth approximately $214,000. Versor Investments LP raised its position in Maximus by 213.5% during the third quarter. Versor Investments LP now owns 8,500 shares of the health services provider's stock worth $792,000 after acquiring an additional 5,789 shares during the last quarter. Crossmark Global Holdings Inc. increased its stake in shares of Maximus by 9.8% during the 3rd quarter. Crossmark Global Holdings Inc. now owns 4,152 shares of the health services provider's stock worth $387,000 after purchasing an additional 369 shares in the last quarter. Covestor Ltd grew its holdings in Maximus by 913.0% during the 3rd quarter. Covestor Ltd now owns 1,246 shares of the health services provider's stock valued at $116,000 after buying an additional 1,123 shares during the last quarter. Finally, Atria Investments Inc acquired a new position in shares of Maximus in the third quarter worth $244,000. 97.21% of the stock is owned by institutional investors and hedge funds.

Maximus Trading Down 7.8 %

MMS traded down $6.89 during trading on Thursday, hitting $81.06. The company's stock had a trading volume of 1,565,438 shares, compared to its average volume of 362,766. Maximus, Inc. has a twelve month low of $76.42 and a twelve month high of $93.97. The firm's 50 day moving average price is $89.35 and its 200-day moving average price is $88.18. The company has a debt-to-equity ratio of 0.61, a current ratio of 1.59 and a quick ratio of 1.59. The stock has a market cap of $4.88 billion, a PE ratio of 18.44 and a beta of 0.77.

Maximus Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Saturday, November 30th. Stockholders of record on Friday, November 15th will be issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.48%. The ex-dividend date of this dividend is Friday, November 15th. Maximus's payout ratio is currently 25.16%.

Insider Buying and Selling

In other Maximus news, insider Michelle F. Link sold 1,363 shares of the stock in a transaction that occurred on Tuesday, October 1st. The shares were sold at an average price of $92.56, for a total value of $126,159.28. Following the completion of the sale, the insider now owns 6,567 shares of the company's stock, valued at $607,841.52. This trade represents a 17.19 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 1.40% of the company's stock.

Maximus Company Profile

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

See Also

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

→ This company will win the AI race (From Porter & Company) (Ad)

Should you invest $1,000 in Maximus right now?

Before you consider Maximus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.

While Maximus currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

NVIDIA Earnings: Can Blackwell Propel the Stock to $200+ in 2025?

NVIDIA Earnings: Can Blackwell Propel the Stock to $200+ in 2025?

NVIDIA's Q3 earnings exceeded expectations with 95% revenue growth and 111% EPS growth. Could $200+ be the next target for NVIDIA stock in 2025?

Related Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
How to Profit from NVIDIA’s Earnings: Short-Term Trading Guide
NVIDIA Nears All-Time Highs: How High Can This AI Leader Climb?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines